
Bioorganic and Medicinal Chemistry p. 1167 - 1176 (1996)
Update date:2022-08-04
Topics:
Kiyoi, Takao
Nakai, Yoshiyuki
Kondo, Hirosato
Ishida, Hideharu
Kiso, Makoto
Hasegawa, Akira
A practical synthesis of the sialyl Lewis X (sLe(x)) pentasaccharide, NeuAcα2-3Galβ1-4(Fucα1-3)GlcNAcβ1-3GalβOEt (1), as a potential blocker for E-selectin has been described. The glycosylation of a trisaccharide acceptor, Fucα(1-3)GlcNAcβ(1-3)GalβOEt, with a disaccharide donor, NeuAcα(2-3)GalβSMe, did not yield the desired sLe(x) pentasaccharide 1 at all. However, the glycosylation of a disaccharide acceptor, GlcNAcβ(1-3)GalβOEt, with a disaccharide donor, NeuAcα(2-3)GalβSMe, quantitatively yielded the tetrasaccharide NeuAcα(2-3)Galβ(1-4) GlcNAcβ(1-3)GalβOEt. This tetrasaccharide is readily converted to the title compound in a high yield by fucosylation, followed by deprotection. The inhibitory activities of compound 1 toward the binding of the natural ligand (sLe(x)) with the E-, P-, and L-selectins were stronger than those of the sLe(x) tetrasaccharide.
View MoreJinan Yijialian Economic and Trade Development Co., Ltd.
Contact:+86 0531-66729596
Address:jinan
VanderArk International Limited
Contact:86-10-82437576
Address:Qing He
ShangHai Ruiyi Medical Technology Co.,Ltd.
Contact:+86-21-54718086
Address:No951 Jianchuan RD,Minhang District
Tianjin Crest Pharmaceutical R&D Co., Ltd. (Tianjin Yao Technology Development Co., Ltd.)(expird)
Contact:+86-22-66211386
Address:Building B5-405, No, 80 4th Avenue, TEDA, Tianjin, China P.R. 300457
Contact:+86-021-58123769
Address:No.780 of Cailun Road,Zhangjiang Hi-tech Park,Pudong,Shanghai
Doi:10.1038/nchem.2672
(2017)Doi:10.1021/jo9612685
(1996)Doi:10.1002/anie.199621411
(1996)Doi:10.1016/j.jorganchem.2003.08.032
(2003)Doi:10.1016/0040-4039(96)01820-5
(1996)Doi:10.1246/cl.1996.987
(1996)